Our Cyp51 LKO model shows that steatosis appears with dietary fats in the absence of dietary cholesterol and its synthesis, while a block in the cholesterol pathway leads to NASH-like features. This evidence concerns the gene CYP51A1 and metabolic dysfunction-associated steatohepatitis.